Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06368622 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evolve China PMCF Study

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 24 of 24 sites
    v8
  2. Study sites: 20 to 24v7
  3. Study sites: 16 to 20v6
  4. Study sites: 12 to 16
    • Eligibility criteria expanded, about 1 word
    v5
  5. Study sites: 11 to 12v4
Show 2 earlier versionsHide 2 earlier versions
  1. Study sites: 10 to 11v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 10
    • Start date changed from estimate of Apr 2024 to Apr 24, 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, multi-center, single-arm, open-label, observational, post-market clinical follow-up. The expected duration of the study is 8 years (including up to 5-years' follow-up). Each subject will be followed up per standard of care (SoC) at each study site.
Trial Details
NCT Number NCT06368622
Lead Sponsor Stryker Neurovascular
Collaborators: Stryker (Beijing) Healthcare Products Co., Ltd
Conditions
(from sponsor)		 Intracranial Aneurysm
Related terms Intracranial Aneurysm
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov